LU84465A1 - Nouveau sel de l'hexamethylenetetramine,son procede de preparation et son application en therapeutique - Google Patents

Nouveau sel de l'hexamethylenetetramine,son procede de preparation et son application en therapeutique Download PDF

Info

Publication number
LU84465A1
LU84465A1 LU84465A LU84465A LU84465A1 LU 84465 A1 LU84465 A1 LU 84465A1 LU 84465 A LU84465 A LU 84465A LU 84465 A LU84465 A LU 84465A LU 84465 A1 LU84465 A1 LU 84465A1
Authority
LU
Luxembourg
Prior art keywords
hexamethylenetetramine
afp
thiazolidine
strains
preparation
Prior art date
Application number
LU84465A
Other languages
English (en)
French (fr)
Inventor
Leonardo De Vincentiis
Original Assignee
Ausonia Farma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ausonia Farma filed Critical Ausonia Farma
Publication of LU84465A1 publication Critical patent/LU84465A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
LU84465A 1982-03-01 1982-11-10 Nouveau sel de l'hexamethylenetetramine,son procede de preparation et son application en therapeutique LU84465A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1990082 1982-03-01
IT8219900A IT1210859B (it) 1982-03-01 1982-03-01 Composto chemioterapico, procedimento per la sua preparazione e relative composizioni farmaceutiche.

Publications (1)

Publication Number Publication Date
LU84465A1 true LU84465A1 (fr) 1983-06-13

Family

ID=11162179

Family Applications (1)

Application Number Title Priority Date Filing Date
LU84465A LU84465A1 (fr) 1982-03-01 1982-11-10 Nouveau sel de l'hexamethylenetetramine,son procede de preparation et son application en therapeutique

Country Status (13)

Country Link
US (1) US4469691A (it)
JP (1) JPS58148885A (it)
BE (1) BE894951A (it)
DE (1) DE3241473A1 (it)
ES (1) ES8401049A1 (it)
FR (1) FR2522326A1 (it)
GB (1) GB2115806A (it)
GR (1) GR77785B (it)
IT (1) IT1210859B (it)
LU (1) LU84465A1 (it)
NL (1) NL8204372A (it)
PT (1) PT75823A (it)
ZA (1) ZA828236B (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495366B1 (en) * 1999-09-03 2002-12-17 Therakos, Inc. Uninterrupted flow pump apparatus and method
US20060198886A1 (en) * 2005-03-01 2006-09-07 Jenkins Richard B Medicament having coated methenamine combined with acidifier

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6804994A (it) * 1967-04-11 1968-10-14
FR2204411B1 (it) * 1972-11-02 1976-03-05 Claude Dufour
US4001231A (en) * 1973-03-29 1977-01-04 William H. Rorer, Inc. Process for making a methenamine salt of an optically active acid

Also Published As

Publication number Publication date
FR2522326A1 (fr) 1983-09-02
ES517348A0 (es) 1983-12-16
ES8401049A1 (es) 1983-12-16
ZA828236B (en) 1983-09-28
PT75823A (en) 1982-12-01
IT8219900A0 (it) 1982-03-01
BE894951A (nl) 1983-03-01
DE3241473A1 (de) 1983-09-15
IT1210859B (it) 1989-09-29
JPS645596B2 (it) 1989-01-31
JPS58148885A (ja) 1983-09-05
NL8204372A (nl) 1983-10-03
GB2115806A (en) 1983-09-14
GR77785B (it) 1984-09-25
US4469691A (en) 1984-09-04

Similar Documents

Publication Publication Date Title
JP4115105B2 (ja) ピラゾール誘導体
US20110077212A1 (en) Therapeutic uses of sglt2 inhibitors
CN101394738A (zh) 用于治疗代谢紊乱的化合物
US20070173544A1 (en) Compounds for the treatment of metabolic disorders
HUE027244T2 (en) Use of hydroxybenzoic acid esters and analogues in the manufacture of a medicament for the prevention and treatment of viral infection
CN101374415A (zh) 用于治疗代谢紊乱的化合物
EP2258705B1 (en) Pharmaceutically acceptable salts of anti-infective quinolone compound
LU81890A1 (fr) Nouvelles spiro-polycyclo-imidazolidinediones et compostion pharmaceutique les contenant
EP2380570A1 (en) Pharmaceutical composition for preventing and treating diabetic nephropathy and preparation method thereof
KR20080061431A (ko) 에이디피-라이보실 사이클레이즈 억제제를 이용한 고혈압 및 당뇨병성 신증의 치료제
CA2949328A1 (en) Low substituted polymyxins and compositions thereof
LU84465A1 (fr) Nouveau sel de l'hexamethylenetetramine,son procede de preparation et son application en therapeutique
WO2011136631A1 (es) N6 -(ferrocenmetil)quinazolin-2,4,6-triamina (h2), sus derivados y profarmacos, como agentes antimicrobianos antiparasitarios, antiprotozoarios y antileishmanias
US9029334B2 (en) Pharmaceutical composition for prevention or treatment of bone diseases comprising spinasterol glucoside derivative
NL7906914A (nl) Hydroxamzuurverbindingen, een werkwijze voor de be- reiding daarvan en farmaceutische preparaten die de hydroxamzuurverbindingen bevatten.
US20060058392A1 (en) Use of a rhein in a therapeutic treatment requiring a rise in the rate of heme oxygenase
FR2989279A1 (fr) Utilisation de l'acide cinnamique pour prevenir ou traiter des infections provoquees par un antigene resistant ou une combinaison d'antigenes
JPS62164626A (ja) 降圧および利尿剤
FR2595697A1 (fr) Derives de benzyl-pyrimidine, leur procede de preparation ainsi que les compositions en contenant
US7704976B2 (en) Use of N-acetyl-D-glucosamine for preparing medicines for urogenital tract infection's treatment and prevention
CA2669871A1 (fr) Composition terpenique anti-microorganisme
BE1028852B1 (fr) PRODROGUE DU 5α-hydroxy-6β-[2-(1H-imidazol-4-yl) éthylamino]cholestan-3β-ol ET COMPOSITIONS PHARMACEUTIQUES LE COMPRENANT POUR UTILISATION DANS LE TRAITEMENT DU CANCER
CN113679728B (zh) 一种磺胺类化合物及其在制备治疗糖尿病和并发症药物中的应用
JPH09194358A (ja) 多価フェノール誘導体含有抗ｍｒｓａ活性医薬組成物
JPH1121243A (ja) 医薬組成物